Takeda’s oral TYK2 inhibitor showed rapid skin clearance in phase 3 psoriasis trials as FDA fast-tracks review; decision expected early 2027.
News|Poll|September 26, 2014
Discolored, Tender Spots on the Face
A 23-year-old African American woman had variably shaped areas of atrophy and hypopigmentation on the face and ear. Your diagnosis?
Advertisement
A 23-year-old African American woman had variably shaped areas of atrophy and hypopigmentation on the face and ear.
Your diagnosis?
Advertisement
Related to this article
Advertisement
Advertisement
Trending on Patient Care Online
1
GLP-1 RAs for Weight Management: A Primary Care Approach to Risk and Monitoring
2
Stroke Incidence Nearly Doubled Among Adults Younger Than 55 Over 3 Decades
3
Safety, Dosing, and Drug Interactions for Dextromethorphan-Bupropion in Agitation
4
FDA Approves Sotatercept-csrk Label Update for Newly Diagnosed PAH
5